USP10 expression correlated significantly with poor prognosis and immune infiltration of patients with PAAD and LIHC; therefore, we investigated whether USP10 expression could affect the prognosis of patients with PAAD and LIHC via immune infiltration (Figure 10). The gene discussed is USP10; the disease is pancreatic adenocarcinoma.